PrintThe Burrill Report (November 1, 2010): Yanking Pharma's Supply Chain (.MP3,15.48 Mb)
The globalization of the life sciences business is raising new concerns for the industry. As companies increasingly look to contract manufacturing organizations overseas or to the growth opportunities in emerging markets, they are finding a need to implement new types of controls and having to protect against counterfeiting, product diversions, and the theft of intellectual property. A new report from Axendia Research and co-sponsored by PriceWaterhouseCoopers highlights these issues. We spoke to Wynn Bailey, pharmaceutical and life sciences advisory services partner for PwC, about the drive towards globalization, the challenges it’s creating for the life sciences industry, and why companies need to change their approach to outsourcing.
October 28, 2010
http://www.burrillreport.com/article-yanking_pharmas_supply_chain.html
.gif)
.gif)
